Product Features
DX Technology
The BIOTRONIK DX System defines a new paradigm in ICD therapy; it offers dual-chamber diagnostics with a single ICD lead, therefore capturing benefits of both single-chamber and dual-chamber ICDs.
Extending MRI Access
Today’s choice defines tomorrow’s care MRI diagnostics are growing in importance, and cardiac device patients are more likely to need this diagnostic scanning.
Improving AF Management
Earlier AF detection, better informed therapy decisions and continuous monitoring of therapy efficacy with BIOTRONIK Home Monitoring.
Product Details
DX technology
The DX system offers complete atrial diagnostics in a single lead, thereby encompassing the benefits of both single- and dual-chamber ICDs. Click Here for more information
BIOTRONIK Home Monitoring
BIOTRONIK Home Monitoring is a remote monitoring service available with cardiac monitors, pacemakers, implantable defibrillators (ICDs) and cardiac resynchronization therapy (CRT) systems. Home Monitoring allows physicians to continuously and reliably survey patients’ device and physiological condition, and alerts responsible healthcare staff of acute health changes within 24 hours. Click Here for more information
Media
DX Technology
Unique single chamber ICD system with atrial diagnostic
DX Game
Click here to access the DX game
Implantable Cardioverter Defbrillator System with Floating Atrial Sensing Dipole: A Single-Center Experience
- The single-lead ICD system with floating atrial dipole provides reliable atrial sensing amplitude over time. The physician, without the implantation of an additional lead, has the atrial information that may be used for discrimination of supraventricular tachyarrhythmia/ventricular tachycardia, for early detection of atrial fibrillation episodes and for evaluation of changes in the patient's heart status.
Case Study: Remote Monitoring in the Management of a Complex Patient with a Single-Lead Dual-Chamber ICD
- The atrial IEGM was instrumental in confirming the device’s rhythm classifications. It appropriately provided ATP during the VT episode, as well as withheld therapies when faced with self-terminating VF.
Implant and Long-Term Evaluation of Atrial Signal Amplification in a Single-Lead ICD
- The single-lead ICD system evaluated reliably amplified P-wave amplitudes by a factor of about three, maintaining this performance during the observed follow-up.
Novel Single-lead ICD Provides SVT Discrimination and Atrial Diagnostics
- The addition of atrial IEGM provides confirmation that the rhythm discriminator both appropriately withheld and treated the different episodes. In fact, clinical evidence suggests that the use of atrial IEGMs dramatically improves a clinician’s accuracy of rhythm classification.